Seagen, Astellas’ Padcev snares full approval and expands into second-line treatment on path to blockbuster land fkansteiner Fri, 07/09/2021 – 16:34 More: Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land Source: fierce
read moreBayer’s Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients nhigginsdunn Fri, 07/09/2021 – 15:32 More: Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients Source: fierce
read moreFDA chief asks for independent investigation into approval of Biogen’s Alzheimer’s drug Aduhelm nhigginsdunn Fri, 07/09/2021 – 13:46 More: FDA chief asks for independent investigation into approval of Biogen's Alzheimer's drug Aduhelm Source: fierce
read moreAfter 5-month hiatus, bluebird bio’s Zynteglo bounces back in Europe with all-clear from safety group nhigginsdunn Fri, 07/09/2021 – 11:21 More: After 5-month hiatus, bluebird bio's Zynteglo bounces back in Europe with all-clear from safety group Source: fierce
read moreEngland’s drug price watchdog rejects Orchard’s groundbreaking gene therapy after first round of talks kdunleavy Fri, 07/09/2021 – 11:07 More: England's drug price watchdog rejects Orchard's groundbreaking gene therapy after first round of talks Source: fierce
read moreCurrently, no preventative vaccines or effective treatments are available for the chikungunya virus More: Valneva’s chikungunya virus vaccine granted breakthrough designation Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals